RCGE - AI Analysis

Compare

Top Page

RockCreek Global Equality ETF (RCGE)

Rating:59Neutral

Price Target:

$31.75

The RockCreek Global Equality ETF (RCGE) has a moderate overall rating, reflecting a mix of strengths and challenges among its holdings. Johnson & Johnson stands out as a key contributor to the fund’s rating due to its strong financial performance and robust growth prospects, supported by positive earnings call insights. However, weaker holdings like Charles River Laboratories, which faces profitability challenges and valuation concerns, may have held back the fund’s overall score. A potential risk for the ETF is its exposure to stocks with valuation concerns, which could limit future growth.

Positive Factors

Strong Year-to-Date Performance

The ETF has delivered solid returns so far this year, indicating strong overall performance.

Global Diversification

The fund invests in companies across multiple countries, reducing reliance on any single geographic region.

Exposure to Stable Sectors

The ETF includes significant allocations to traditionally stable sectors like Financials and Health Care.

Negative Factors

High Expense Ratio

The ETF charges a relatively high fee, which could eat into investor returns over time.

Underperforming Holdings

Some top holdings, such as Charles River Labs and Land Securities Group, have shown weaker year-to-date performance.

Limited Emerging Market Exposure

The fund has minimal exposure to emerging markets, potentially missing out on higher-growth opportunities.

RCGE vs. SPDR S&P 500 ETF (SPY)

AUM79.23M

RegionGlobal

Expense Ratio0.95%

Beta0.68

IssuerRockCreek

Inception DateFeb 26, 2025

Dividend YieldN/A

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume33

30 Day Avg. Volume445

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

31.75

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering202

RCGE Summary

The RockCreek Global Equality ETF (RCGE) is an actively managed fund that invests in large companies worldwide, focusing on those committed to gender equality in their corporate structures. It includes well-known firms like Johnson & Johnson and Exelon, offering exposure to industries such as healthcare, financials, and technology. This ETF is ideal for investors who want to align their investments with social values while aiming for growth and diversification. However, new investors should note that the fund’s performance can fluctuate with the broader market, and its focus on gender-balanced companies may limit exposure to other potentially high-performing firms.

How much will it cost me?The RockCreek Global Equality ETF (RCGE) has an expense ratio of 0.95%, which means you’ll pay $9.50 per year for every $1,000 invested. This is higher than average because it’s an actively managed fund, requiring more research and oversight compared to passively managed ETFs that track an index.

What would affect this ETF?The RockCreek Global Equality ETF (RCGE) could benefit from growing global interest in socially responsible investing and corporate diversity, as well as potential economic growth in both developed and emerging markets. However, it may face challenges from rising interest rates, which could impact sectors like real estate and financials, or economic slowdowns that affect large-cap companies globally. Additionally, its focus on gender equality may limit its investment universe, potentially reducing diversification compared to broader ETFs.

RCGE Top 10 Holdings

The RockCreek Global Equality ETF is leaning heavily on financials, with names like ANZ Group Holdings providing stability through strong fundamentals and attractive dividends, while Kering SA from the consumer sector is rising on positive momentum despite mixed profitability. Johnson & Johnson in healthcare remains steady, backed by robust growth prospects, while Charles River Labs is struggling to gain traction due to profitability challenges. The fund’s global exposure and diverse sector mix offer balance, but its tilt toward financials and healthcare suggests a focus on stability and resilience in uncertain markets.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
CRL	Charles River Labs	0.62%	$494.37K	$9.70B	4.70%	60 Neutral
KER	Kering SA	0.60%	$478.79K	€40.66B	36.59%	68 Neutral
NOVT	Novanta	0.59%	$464.43K	$4.63B	-25.51%	70 Neutral
F	Ford Motor	0.58%	$460.58K	$55.08B	16.62%	74 Outperform
GM	General Motors	0.58%	$459.06K	$64.98B	31.58%	75 Outperform
	―	0.57%	$450.40K	―	―	―
ENRG	Energix	0.57%	$449.91K	8.37B	20.76%	66 Neutral
LAND	Land Securities Group plc REIT	0.56%	$441.25K	£4.83B	3.86%	74 Outperform
IG	Italgas S.p.A.	0.55%	$438.34K	€8.89B	62.27%	69 Neutral
EXC	Exelon	0.54%	$429.48K	$48.51B	19.49%	68 Neutral

RCGE Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

27.82

Positive

100DMA

27.33

Positive

200DMA

Market Momentum

MACD

0.13

Negative

RSI

65.44

Neutral

STOCH

99.98

Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RCGE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 27.88, equal to the 50-day MA of 27.82, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.13 indicates Negative momentum. The RSI at 65.44 is Neutral, neither overbought nor oversold. The STOCH value of 99.98 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RCGE.

RCGE Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
RCGE	―	―	$79.23M	0.95%	59 Neutral
FYEE	―	―	$77.56M	0.00%	75 Outperform
GPT	―	―	$19.65M	0.69%	65 Neutral
FBUF	―	―	$12.02M	0.48%	74 Outperform
BLCR	―	―	$10.61M	0.36%	72 Outperform
JDIV	―	―	$8.09M	0.47%	66 Neutral

Performance Comparison

RCGE

RockCreek Global Equality ETF

28.35

3.75

15.24%

FYEE

Fidelity Yield Enhanced Equity ETF

―

GPT

Intelligent Alpha Atlas ETF

―

FBUF

Fidelity Dynamic Buffered Equity ETF

―

BLCR

BlackRock Large Cap Core ETF

―

JDIV

JPMorgan Dividend Leaders ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents